Cited by 438Antifungal resistance and susceptibilityFungal Infections and StudiesOcular Infections and Treatments

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance

Morgan, Juliette, Meltzer, Martin I., Plikaytis, Brian D., Sofair, Andre N., Huie-White, Sharon, Wilcox, Steven, Harrison, Lee H., Seaberg, Eric C., Hajjeh, Rana A., Teutsch, Steven M.·2005·Infection Control & Hospital Epidemiology

DOI 10.1086/502581

Open this paper in CoChat — free account

Abstract

Objective: To determine the mortality, hospital stay, and total hospital charges and cost of hospitalization attributable to candidemia by comparing patients with candidemia with control-patients who have otherwise similar illnesses. Prior studies lack broad patient and hospital representation or cost-related information that accurately reflects current medical practices. Design: Our case-control study included case-patients with candidemia and their cost-related data, ascertained from laboratory-based candidemia surveillance conducted among all residents of Connecticut and Baltimore and Baltimore County, Maryland, during 1998 to 2000. Control-patients were matched on age, hospital type, admission year, discharge diagnoses, and duration of hospitalization prior to candidemia onset. Results: We identified 214 and 529 sets of matched case-patients and control-patients from the two locations, respectively. Mortality attributable to candidemia ranged between 19% and 24%. On multivariable analysis, candidemia was associated with mortality (OR, 5.3 for Connecticut and 8.5 for Baltimore and Baltimore County;P< .05), whereas receiving adequate treatment was protective (OR, 0.5 and 0.4 for the two locations, respectively;P< .05). Candidemia itself did not increase the total hospital charges and cost of hospitalization; when treatment status was accounted for, having received adequate treatment for candidemia significantly increased the total hospital charges and cost of hospitalization ($6,000 to $29,000 and $3,000 to $22,000, respectively) and the length of stay (3 to 13 days). Conclusion: Our findings underscore the burden of candidemia, particularly regarding the risk of death, length of hospitalization, and cost associated with treatment (Infect Control Hosp Epidemiol 2005;26:540-547).

Integrity signals

Registry

Crossref · 10.1086/502581

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality
Pittet, D. (1994) · JAMA · doi:10.1001/jama.271.20.1598 · Cited by 1,354
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Nosocomial Bloodstream Infection in Critically III Patients
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 946
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Self-citation
Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636
Trends in Infectious Diseases Mortality in the United States
Pinner, R. W. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270029027 · Cited by 487

Flagged first, then by citations

Show all 26 references

Research works printed but not linked: 5

Haddix, 2003, Prevention Effectiveness, 53
Consumer Price Index
ChimeData Program
Health Services Cost Review
10.1001/archinte.1995.00430110089009 · DOI · Paper page

Sorted by citations

Items 201–300 of 438

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
Ostermann, H., Solano, C., Jarque, I., García‐Vidal, C., Gao, X., Barrueta, J. A., de Salas-Cansado, M., Stephens, J., Xue, M., Weber, B., et al. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-52 · Cited by 20
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
Viscoli, C., Bassetti, M., Castagnola, E., Cesaro, S., Menichetti, F., Ratto, S., Tascini, C., & Giacobbe, D. R. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0725-7 · Cited by 19
The Diagnostic and Therapeutic Approach to Fungal Infections in Critical Care Settings
Zaragoza, R., & Pemán, J. (2008) · Cited by 20
Antimicrobial Stewardship Review of Automated Candidemia Alerts Using the Epic Stewardship Module Improves Bundle-of-Care Adherence
Pettit, N. N., Han, Z., Nguyen, C. T., Choksi, A. R., Charnot‐Katsikas, A., Beavis, K. G., Tešić, V., & Pisano, J. C. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz412 · Cited by 20
Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis
Verma, N., Roy, A., Singh, S., Pradhan, P., Garg, P., & Singh, M. (2021) · Medical Mycology · doi:10.1093/mmy/myab069 · Cited by 20
Effect of Statin Use on Outcomes of Adults with Candidemia
Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Mykietiuk, A., Manzur, A., Gudiol, C., Pemán, J., Viasus, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077317 · Cited by 20
“Importantly, some investigators report that overall mortality has not decreased over the past decades [1-4].”
Background
Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: An observational nine-year single center study in Mexico
Treviño‐Rangel, R. D. J., Peña-López, C. D., Hernández-Rodríguez, P. A., Beltrán-Santiago, D., & González, G. M. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.01.005 · Cited by 20
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study
Orasch, C., Mertz, D., Garbino, J., van Delden, C., Emonet, S., Schrenzel, J., Zimmerli, S., Damonti, L., Mühlethaler, K., Imhof, A., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2017.12.018 · Cited by 19
Epidemiology and Risk Factors of Candidemia a 8-Year Retrospective Study from a Teaching Hospital in China
Chen, L., Xie, Z., & Jian, J. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s471171 · Cited by 19
Geographic Trends in Invasive Candidiasis
Nishikaku, A. S., Melo, A. S. D. A., & Colombo, A. L. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0033-7 · Cited by 19
Impact of yeast–bacteria coinfection on the detection of Candida sp. in an automated blood culture system
Cateau, E., Cognée, A.-S., Tran, T. C., Vallade, E., Garcia, M., Belaz, S., Kauffmann‐Lacroix, C., & Rodier, M. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.12.012 · Cited by 19
Evaluation of a Rapid Fungal Detection Panel for Identification of Candidemia at an Academic Medical Center
Bomkamp, J. P., Sulaiman, R., Hartwell, J. L., Desai, A., Winn, V., Wrin, J. E., Kussin, M. L., & Hiles, J. J. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01408-19 · Cited by 19
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan
Al‐Shayyab, M. H., Abu-Hammad, O. A., AL-Omiri, M. K., & Dar-Odeh, N. S. (2015) · International Dental Journal · doi:10.1111/idj.12173 · Cited by 19
An observational study on the epidemiological and mycological profile of Candidemia in ICU patients
Kotwal, A., Biswas, D., Sharma, J. P., Gupta, A., & Jindal, P. (2011) · Medical Science Monitor · doi:10.12659/msm.882053 · Cited by 19
Bacterial Derived Carbohydrates Bind Cyr1 and Trigger Hyphal Growth in Candida albicans
Burch, J. M., Mashayekh, S., Wykoff, D. D., & Grimes, C. L. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00154 · Cited by 19
The Paralogous Transcription Factors Stp1 and Stp2 of Candida albicans Have Distinct Functions in Nutrient Acquisition and Host Interaction
Miramón, P., Pountain, A. W., van Hoof, A., & Lorenz, M. C. (2020) · Infection and Immunity · doi:10.1128/iai.00763-19 · Cited by 19
Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 18
Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections
Lee, I., Morales, K. H., Zaoutis, T. E., Fishman, N. O., Nachamkin, I., & Lautenbach, E. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.02.016 · Cited by 18
Photodynamic antimicrobial chemotherapy (PACT) using toluidine blue inhibits both growth and biofilm formation by Candida krusei
da Silva, B. G. M., Carvalho, M. L., Rosseti, I. B., Zamunér, S. R., & Costa, M. S. (2018) · Lasers in Medical Science · doi:10.1007/s10103-017-2428-y · Cited by 17
Candida
Dignani, M. C., Solomkin, J. S., & Anaissie, E. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00008-6 · Cited by 19
Candida albicans growth and germ tube formation can be inhibited by simple diphenyl diselenides [(PhSe)2, (MeOPhSe)2, (p-Cl-PhSe)2, (F3CPhSe)2] and diphenyl ditelluride
Rosseti, I. B., Wagner, C., Fachinetto, R., Taube, P. S., & Costa, M. S. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01888.x · Cited by 18
Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit
Smith, J. A., & Kauffman, C. A. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cf25 · Cited by 18
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains
Orofino, F., Truglio, G. I., Fiorucci, D., D’Agostino, I., Borgini, M., Poggialini, F., Zamperini, C., Dreassi, E., Maccari, L., Torelli, R., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.105865 · Cited by 17
Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non‐albicans Candida species
Cornely, O. A., Vázquez, J. A., Waele, J. J. D., Betts, R. F., Rotstein, C., Nucci, M., Pappas, P. G., & Ullmann, A. J. (2013) · Mycoses · doi:10.1111/myc.12104 · Cited by 17
Cost Analysis of Fluconazole Prophylaxis for Prevention of Neonatal Invasive Candidiasis
Swanson, J. R., Vergales, J., Kaufman, D. A., & Sinkin, R. A. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001068 · Cited by 17
Candida parapsilosis: principal causa de candidemia en un hospital de referencia para adultos de Costa Rica
Villalobos, J. M., Castro, J. A., Montoya, A. A. A., Peláez, M. C., Somogyi, T., & Sandoval, L. (2016) · Revista chilena de infectología · doi:10.4067/s0716-10182016000200005 · Cited by 17
The additional costs of catheter-related bloodstream infections in intensive care units
Nakamura, I., Fukushima, S., Hayakawa, T., Sekiya, K., & Matsumoto, T. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.05.022 · Cited by 17
Impacto de la infección nosocomial en un hospital de Bogotá (Colombia): efectos en mortalidad y costos
Saavedra, C., Ordóñez, K., & Díaz, J. (2015) · Revista chilena de infectología · doi:10.4067/s0716-10182015000200004 · Cited by 17
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies
Magliani, W. (2008) · Frontiers in bioscience · doi:10.2741/3199 · Cited by 17
Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico
Pemán, J., & Zaragoza, R. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.002 · Cited by 16
Comparing the Profile of Respiratory Fungal Pathogens amongst Immunocompetent and Immunocompromised Hosts, their Susceptibility Pattern and Correlation of Various Opportunistic Respiratory Fungal Infections and their Progression in Relation to the CD4+T-cell Counts
Roohani, A. H., Fatima, N., Shameem, M., Khan, H. M., Khan, P. A., & Akhtar, A. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_258 · Cited by 16
Micafungin for candidiasis
Pappas, P. G. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02112.x · Cited by 16
Guías de práctica clínica para el manejo de la candidiasis: actualización del 2009, de la Infectious Diseases Society of America
Pappas, P. G., Kauffman, C. A., Andes, D. R., Benjamin, D. K., Calandra, T., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B. J., Ostrosky-Zeichner, L. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598961 · Cited by 16
Management of candidaemia and invasive candidiasis in critically ill patients
Chahoud, J., Kanafani, Z. A., & Kanj, S. S. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.008 · Cited by 15
Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study
Zilberberg, M. D., Yu, H.-T., Chaudhari, P., Emons, M. F., Khandelwal, N., & Shorr, A. F. (2014) · Critical Care · doi:10.1186/s13054-014-0590-1 · Cited by 15
Validation of 24-Hour Flucytosine MIC Determination by Comparison with 48-Hour Determination by the Clinical and Laboratory Standards Institute M27-A3 Broth Microdilution Reference Method
Lockhart, S. R., Bolden, C. B., Iqbal, N. J., & Kuykendall, R. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05479-11 · Cited by 15
Candida albicans ‐induced leukotriene biosynthesis in neutrophils is restricted to the hyphal morphology
Fischer, J., Gresnigt, M. S., Werz, O., Hube, B., & Garscha, U. (2021) · The FASEB Journal · doi:10.1096/fj.202100516rr · Cited by 15
Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species
Sakamoto, Y., Kawabe, K., Suzuki, T., Sano, K., Ide, K., Nishigaki, T., Enoki, Y., Taguchi, K., Koike, H., Kato, H., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080596 · Cited by 17
Candida Species
Edwards, J. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00257-5 · Cited by 14
Diagnóstico de infecção por Candida: avaliação de testes de identificação de espécies e caracterização do perfil de suscetibilidade
Mímica, L. M. J., Ueda, S. M. Y., Martino, M. D. V., Navarini, A., & Martini, I. J. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000100005 · Cited by 14
Epidemiology and Evolution of Fungal Pathogens in Plants and Animals
Gladieux, P., Byrnes, E. J., Aguileta, G., Fisher, M. C., Billmyre, R. B., Heitman, J., & Giraud, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-799942-5.00004-4 · Cited by 19
Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain
Grau, S., Salavert, M., Laderas, J. C. P., Vargas, M., Barrueta, J. A., & Mir, N. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.05.004 · Cited by 13
The Candida albicans Exocyst Subunit Sec6 Contributes to Cell Wall Integrity and Is a Determinant of Hyphal Branching
Chavez‐Dozal, A. A., Bernardo, S. M., Rane, H. S., Herrera, G., Kulkarny, V. V., Wagener, J., Cunningham, I., Brand, A., Gow, N. A. R., & Lee, S. A. (2015) · Eukaryotic Cell · doi:10.1128/ec.00028-15 · Cited by 13
Retracted
Antimicrobial Lipstick: Bio-Based Composition against Viruses, Bacteria, and Fungi
Tuñón‐Molina, A., Cano-Vicent, A., & Serrano‐Aroca, Á. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c19460 · Cited by 13
Effects of carbapenems and their combination with amikacin on murine gut colonisation by Candida albicans
Samonis, G., Galanakis, E., Ntaoukakis, M., Sarchianaki, E., Spathopoulou, T., Dimopoulou, D., Kofteridis, D. P., & Maraki, S. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02212.x · Cited by 13
Nosocomial candidemia at a general hospital: prognostic factors and impact of early empiric treatment on outcome (2002–2005)
Gómez, J., García‐Vázquez, E., Espinosa, C., Ruiz, J., Canteras, M., Hernández‐Torres, A., Baños, V., Herrero, J. A., & Valdés, M. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.06.066 · Cited by 13
Clinical Alert
Todd, B. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000515233.51795.b3 · Cited by 12
Molecular epidemiology of late recurrent candidaemia—a population-based study in Iceland
Ásmundsdóttir, L. R., Erlendsdóttir, H., Gísladóttir, A., & Gottfreðsson, M. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03595.x · Cited by 11
Effect of Cinnamaldehyde on C. albicans cell wall and (1,3)- β – D-glucans in vivo
Deng, J., Zhang, X., Wang, G., Luo, J.-N., Wang, J., Qi, X., & Li, Y. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03468-y · Cited by 13
An Overview Of Changing Trends In Systemic Fungal Infections
Das, R. (2012) · Cited by 12
Recurrent Candidemia: Trends and Risk Factors Among Persons Residing in 4 US States, 2011–2018
Seagle, E. E., Jackson, B. R., Lockhart, S. R., Jenkins, E. N., Revis, A., Farley, M. M., Harrison, L. H., Schaffner, W., Markus, T. M., Pierce, R. A., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac545 · Cited by 11
Self-citation
An approach to develop clinical prediction rule for candidemia in critically ill patients: A retrospective observational study
Jameran, A. S., Cheah, S. K., Tzar, M. N., Musthafa, Q. A., Low, H. J., Maaya, M., & Rahman, R. A. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.06.018 · Cited by 11
Combined Antibiofilm Activity of Synthetic Peptides and Antifungal Drugs Against Candida Spp.
Bezerra, L. P., Silva, A. F. B., Santos‐Oliveira, R., Alencar, L. M. R., Amaral, J. L., Neto, N. A. S., Silva, R. G. G., Belém, M. O., de Andrade, C. R., Oliveira, J. T., et al. (2022) · Future Microbiology · doi:10.2217/fmb-2022-0053 · Cited by 12
Phytochemical Analysis, Antifungal, and Antioxidant Properties of Two Herbs (Tristemma mauritianum and Crassocephalum bougheyanum) and One Tree (Lavigeria macrocarpa) Species
Kengne, I. C., Fankam, A. G., Yamako, E. K., & Tamokou, J. (2023) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2023/2565857 · Cited by 11
Enhancement of antifungal activity and transdermal delivery of 5-flucytosine via tailored spanlastic nanovesicles: statistical optimization, in-vitro characterization, and in-vivo biodistribution study
Safhi, A. Y., Naveen, N. R., Rolla, K. J., Bhavani, P. D., Kurakula, M., Hosny, K. M., Abualsunun, W. A., Alissa, M., Alsalhi, A., Alahmadi, A. A., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1321517 · Cited by 11
Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections
Lewis, R. E. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ff7e10 · Cited by 11
Red Regional de Laboratorios para la Vigilancia de las Infecciones Fúngicas Invasoras y Susceptibilidad a los Antifúngicos
Cuenca‐Estrella, M., Rodrı́guez-Tudela, J. L., Córdoba, S. B., Melhem, M. D. S. C., Szeszs, M. W., Castañeda, E., Martínez, G., & Gabastou, J.-M. (2008) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892008000200014 · Cited by 11
Compliance With Infectious Diseases Society of America Guidelines for Ophthalmologic Evaluation of Patients With Candidemia
Popovich, K. J., Malani, P., Kauffman, C. A., & Cinti, S. K. (2007) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318059b95f · Cited by 11
Pharmacoeconomics of voriconazole
Rubio‐Terres, C., & Grau, S. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003649555 · Cited by 10
Evaluation for Metastatic Candida Focus and Mortality at Candida-associated Catheter-related Bloodstream Infections at the Pediatric Hematology-oncology Patients
Duzgol, M. U., Böncüoğlu, E., Kiymet, E., Kara, A. A., Erdem, M., Al, I. O., Demirag, B., Zihni, C., Karapinar, T. H., Oymak, Y., et al. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002197 · Cited by 10
Novel Polymorphic Multilocus Microsatellite Markers to Distinguish Candida tropicalis Isolates
Fan, X., Xiao, M., Liu, P., Chen, S., Kong, F., Wang, H., Zhang, L., Hou, X., & Xu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166156 · Cited by 10
Epidemiology and Outcomes of Candidemia in a Referral Center in Tehran.
Salehi, M., Ghomi, Z., Mirshahi, R., Manshadi, S. A. D., & Rezahosseini, O. (2019) · Europe PMC (PubMed Central) · doi:10.22088/cjim.10.1.73 · Cited by 10
Antifungal activities of different fractions of Salvia rhytidea Benth as a valuable medicinal plant against different Candida species in Kerman province (Southeast of Iran)
zahabi, Z. F., Sharififar, F., Almani, P. G. N., & Salari, S. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100624 · Cited by 10
Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
Rotstein, C., Cragin, L. S., Laverdière, M., Garber, G. E., Bow, E. J., Scalera, A., Roberts, C. S., Sorenson, S. V., & Panel, T. C. E. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/161835 · Cited by 10
Perfil de sensibilidade do gênero Candida a antifúngicos em um hospital de referência da Região Norte do Brasil
Nunes, E. B., Nunes, N. B., Monteiro, J. C. M. S., & Paes, A. L. V. (2011) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232011000400004 · Cited by 10
Incidencia de bacteriemia asociada a catéter venoso central en una unidad de cuidados intensivos
Espiau, M., Pujol, M., Campins, M., Planes, A. M. C., Peña-López, Y., Balcells, J., & Mas, J. R. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.03.002 · Cited by 10
Clinical insights into mixed Candida and bacterial bloodstream infections: a retrospective cohort study
Huang, H., Lin, Y., Lu, P., Wang, Y., Chen, T., Chang, K., & Lin, S. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01684-25 · Cited by 9
Healthcare‐associated candidemia—A distinct entity?
Gulia, J., Aryal, S., Saadlla, H., & Shorr, A. F. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.652 · Cited by 9
Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model
Beredaki, M.-I., Georgiou, P., Siopi, M., Kanioura, L., Andes, D. R., Arendrup, M. C., Mouton, J. W., & Meletiadis, J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00170-20 · Cited by 9
Update: invasive Pilzinfektionen: Diagnose und Therapie in der operativen Intensivmedizin
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · Cited by 9
Nitric oxide-loaded nano- and microparticle platforms serving as potential new antifungal therapeutics
Liu, S., Zamith‐Miranda, D., Almeida‐Paes, R., da Silva, L. B. R., Nacharaju, P., & Nosanchuk, J. D. (2023) · Fungal Biology · doi:10.1016/j.funbio.2023.01.007 · Cited by 9
The Impact of COVID-19 on the Epidemiology and Outcomes of Candidemia: A Retrospective Study from a Tertiary Care Center in Lebanon
Zakhem, A. E., Mahmoud, O. K., Zakhour, J., Nahhal, S. B., Ghawi, N. E., Omran, N., Sheikh, W. G. E., Tamim, H., & Kanj, S. S. (2023) · Journal of Fungi · doi:10.3390/jof9070769 · Cited by 9
Unresolved issues in the diagnosis of catheter related candidemia: A position paper
Soriano-Martín, A., Muñóz, P., García‐Rodríguez, J., Cantón, R., Vena, A., Bassetti, M., & Bouza, E. (2023) · Revista Española de Quimioterapia · doi:10.37201/req/112.2023 · Cited by 10
Study on the comparative activity of echinocandins on murine gut colonization byCandida albicans
Maraki, S., Hamilos, G., Dimopoulou, D., Andrianaki, A. M., Karageorgiadis, A. S., Kyvernitakis, A., Lionakis, S., Kofteridis, D. P., & Samonis, G. (2015) · Medical Mycology · doi:10.1093/mmy/myv028 · Cited by 9
Characteristics of late recurrent candidemia in adult patients
Ala‐Houhala, M., & Anttila, V. (2020) · Mycoses · doi:10.1111/myc.13236 · Cited by 9
Adherence to National Consensus Guidelines and Association with Clinical Outcomes in Patients with Candidemia
Junco, S. J., Chehab, S., Giancarelli, A., Bowman, M. C., & Turner, R. B. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211018722 · Cited by 9
Total Synthesis of Marine-Derived Azole Resistant Antifungal Agent (–)-Melearoride A and Antibiotic (–)-PF1163B
Pabbaraja, S., & Yasam, B. K. (2022) · SynOpen · doi:10.1055/a-1942-6969 · Cited by 9
Update: invasive Pilzinfektionen
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · doi:10.1007/s00101-009-1655-4 · Cited by 11
Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia
Szilágyi-Tolnai, E., Fidler, G., Szász, R., Rejtő, L., Nwozor, K. O., Bíró, S., & Paholcsek, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-73556-5 · Cited by 10
Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran
Kord, M., Salehi, M., Hashemi, S. J., Abdollahi, A., Alijani, N., Maleki, A., Mahmoudi, S., Ahmadikia, K., Parsameher, N., Moradi, M., et al. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.3.11207 · Cited by 10
Candida spp. DNA Extraction in the Age of Molecular Diagnosis
Codreanu, S. I., & Ciurea, C. N. (2023) · Microorganisms · doi:10.3390/microorganisms11040818 · Cited by 9
Epidemiology of Candidemia, Antifungal Susceptibilities of Candida Species and Their Impact on Mortality in Adult Patients Admitted to Akdeniz University Hospital
Kahramanmaras Afsin Devlet Hastanesi, I. H. V. K. M. K., Kolak, C. C., Daloğlu, A. E., Özhak, B., Öğünç, D., & Günseren, F. (2020) · Klimik Dergisi/Klimik Journal · doi:10.5152/kd.2019.71 · Cited by 9
Synthesis and antifungal activities of some benzimidazolyl-chalcones, analogues of chlormidazole
Sissouma, D., Ouattara, M., & Mamidou, W. K. (2015) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp2014.4171 · Cited by 8
Nosocomial candidaemia in a Finnish tertiary care centre during 1987–2004
Poikonen, E., Lyytikäinen, O., Anttila, V., Kuusela, P., Koukila-Kähkölä, P., Ollgren, J. P., & Ruutu, P. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540903022824 · Cited by 8
Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units
Pammi, M., Eddama, O., & Weisman, L. E. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006068.pub2 · Cited by 8
Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals
Lodise, T. P., Garey, K. W., Aram, J. A., Nathanson, B. H., & Redell, M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf472 · Cited by 7
Oral Myco- and Bacteriobiota and Yeast Infections in Mechanically Ventilated COVID-19 Patients
Gregorczyk‐Maga, I., Kania, M., Sulik‐Tyszka, B., Namysł, M., Sepioło, A., Romaniszyn, D., Jachowicz-Matczak, E., & Wójkowska‐Mach, J. (2023) · Microorganisms · doi:10.3390/microorganisms11061442 · Cited by 6
Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification
Grant, M. L., Parajuli, S., Deleon-Gonsalves, R., Potula, R., & Truant, A. L. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/4094932 · Cited by 7
Candidemia in critically ill patient: An analysis of daily antifungal therapy related costs
Vandijck, D. M., Blot, S. I., Labeau, S. O., Buyle, F. M., Depaemelaere, M., Vandewoude, K., & Decruyenaere, J. M. A. (2008) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2008.04.006 · Cited by 7
Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis
Saroukolaei, S. A., Ghabaee, M., Shokri, H., Khosravi, A., & Badiei, A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.33292 · Cited by 7
Bloodstream Infection: An Ounce of Prevention Is a Ton of Work
Safdar, N. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502576 · Cited by 7
Epidemiological Characterization of Opportunistic Mycoses between the Years 2006 and 2010 in Korea
Park, J.-S., Cho, S.-H., Youn, S.-K., Bak, Y.-S., Yu, Y.-B., & Kim, Y. K. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1508.08059 · Cited by 7
Rezafungin for suppressive therapy of Candida auris in a patient with a left ventricular assist device (LVAD)
Stack, M. A., Ostrosky-Zeichner, L. L., Hasbun, R., Park, S. O., Babic, J. T., & Kapadia, M. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02232 · Cited by 7
Candidemia: impacto de los estudios epidemiológicos en la terapéutica y en el pronóstico de una infección grave
Almirante, B., & Cuenca‐Estrella, M. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.03.002 · Cited by 5
Anti-biofilm peptides can rescue fluconazole and amphotericin B efficacies against Candida albicans
Kissmann, A., Mildenberger, V., Krämer, M., Alpízar-Pedraza, D., Martell-Huguet, E. M., Perez‐Erviti, J. A., Çetinkaya, A., Pietrasik, J., Otero‐González, A. J., Firacative, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-10315-4 · Cited by 7
The Combination of 3-Hydrazinoquinoxaline-2-Thiol with Thymoquinone Demonstrates Synergistic Activity Against Different Candida Strains
Bazuhair, M. A., Alsieni, M., Abdullah, H., Mokhtar, J. A., Attallah, D. M., Abujamel, T. S., Alkuwaity, K. K., Niyazi, H. A., Niyazi, H. A., AbdulMajed, H., et al. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s464287 · Cited by 7
A novel renal epithelial cell in vitro assay to assessCandida albicansvirulence
Szabo, E. K., & MacCallum, D. M. (2013) · Virulence · doi:10.4161/viru.27046 · Cited by 6
Evaluación de las tarjetas AST-YSO1 del sistema Vitek 2 para determinar la sensibilidad a antifúngicos de levaduras del género Candida
Ochiuzzi, M. E., Arechavala, A. I., Guelfand, L. I., Maldonado, I., & Soloaga, R. N. (2014) · Revista Argentina de Microbiología · doi:10.1016/s0325-7541(14)70058-6 · Cited by 6
Clinical factors affecting costs in patients receiving systemic antifungal therapy in intensive care units in Greece: Results from the ESTIMATOR study
Armaganidis, A., Nanas, S., Antoniadou, E., Mandragos, K. E., Liakou, K., Koutsoukou, A., Baltopoulos, G. J., Nakos, G., Kounougeri, A., Ganas, K., et al. (2017) · Mycoses · doi:10.1111/myc.12616 · Cited by 6
Production of novel antifungal compounds from actinomycetes isolated from waste dump soil in Western Uganda
Adamu, A. A., Ntulume, I., Odda, J., & Okech, M. A. (2017) · African Journal of Microbiology Research · doi:10.5897/ajmr2017.8588 · Cited by 6

Authors: Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M.
Affiliations: Centers for Disease Control and Prevention (US)
Johns Hopkins University (US)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author: Morgan, Juliette
ORCID: Morgan, Juliette
Meltzer, Martin I.
Harrison, Lee H.
Seaberg, Eric C.
Hajjeh, Rana A.
Teutsch, Steven M.
Venue: Infection Control & Hospital Epidemiology
Publisher: Cambridge University Press (CUP)
Published: 2005-06
Volume: 26
Issue: 6
Pages: 540-547
ISSN: 0899-823X (ISSN-L)
1559-6834
DOI: 10.1086/502581
OpenAlex: W2138648278
Semantic Scholar: fbb5a839e0dc3b43795b4bba8e920640a069b23b
Cited by: 437
References: 26
Citations by year: 2026: 9 · 2025: 13 · 2024: 16 · 2023: 15 · 2022: 18 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 10 · 2017: 19 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 26 · 2012: 36
FWCI: 11.94
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 4038 d)
Locations: Infection Control and Hospital Epidemiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords: candidemia, excess mortality, length of hospital stay, hospital costs, fungemia, Connecticut, Baltimore
MeSH terms: Adolescent, Adult, Candidiasis, Child, Child, Preschool, Connecticut, Cross Infection, Female, Humans, Infant, Length of Stay, Male, Middle Aged, Population Surveillance, Baltimore, Multivariate Analysis, Linear Models, Case-Control Studies, Fungemia, Hospital Mortality, Cost of Illness, Age Distribution, Hospital Costs, Hospital Charges

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks